Beyond the storm — subacute toxicities and late effects in children receiving CAR T cells
Haneen Shalabi(Center for Cancer Research), Nirali N. Shah(National Institutes of Health), Juliane Gust(University of Washington), Timothy S. Olson(Children's Hospital of Philadelphia), Javed Khan(Alzheimer’s Disease Neuroimaging Initiative), Véronique Nussenblatt(Johns Hopkins University), Agne Taraseviciute(Seattle Children's Hospital), Allison Barz Leahy(Memorial Sloan Kettering Cancer Center), Kevin J. Curran(Memorial Sloan Kettering Cancer Center), Pamela L. Wolters(National Cancer Center), Stephan A. Grupp(Children's Hospital of Philadelphia), Carlos Sandi(St. Baldrick's Foundation), Rebecca Gardner(Center for Infectious Disease Research), Marcelo C. Pasquini(Cleveland Clinic), Theodore W. Laetsch(Children's Hospital of Philadelphia), Lori Wiener(National Institutes of Health), Colleen Annesley(Unknown), Hao‐Wei Wang(National Institutes of Health), Joshua A. Hill(Seattle Pacific University), Christine Duncan(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Michael A. Pulsipher(Primary Children's Hospital)
Cited by 68
Related Papers
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
|Journal of Clinical Oncology|2015|2.6k
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
|Science Translational Medicine|2014|2.5k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.1k
Comprehensive Analysis of Hypermutation in Human Cancer
|Cell|2017|795